AbbVie has grown revenue 4.8% a year over three years and 3.7% a year over five, with earnings per share compounding at −10%. Revenue growth, 3-year annual rate: +4.8% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +3.7%, growth has picked up over the last three years. Earnings per share, 3-year rate: −10%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 15, FY2011 to FY2025, as filed.

ABBVAbbVie

HealthcareUSD

$262.84

$193.4652 weeks$266.10

Is it growing?

Is ABBV growing?

AbbVie has grown revenue 4.8% a year over three years and 3.7% a year over five, with earnings per share compounding at −10%.

+4.8%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +3.7%
Revenue growth, 5-year rate · +4.8% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −10%
Earnings per share, 3-year rate · revenue +4.8% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed